Cellular Biomedicine Group, Inc. 4
4 · Cellular Biomedicine Group, Inc. · Filed Mar 4, 2016
Insider Transaction Report
Form 4
Cao Wei (William)
DirectorPresident and COO
Transactions
- Exercise/Conversion
Common Stock
2016-03-02$5.40/sh+7,500$40,500→ 181,972 total - Sale
Common Stock
2016-03-02$17.55/sh−7,500$131,625→ 174,472 total - Exercise/Conversion
Non- Qualified Stock Option (right to buy) (2013 Plan)
2016-03-02+7,500→ 42,500 totalExercise: $5.40Exp: 2023-09-30→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- [F2]The option vests according to the following schedule: 1/36th per month following the vesting commencement date of September 30, 2013.